Study develops a strategy to noninvasively track tumor-associated macrophages

A Ludwig Cancer Research study has developed a strategy to noninvasively track immune cells known as macrophages within brain and breast tumors in living mice. Cancers often recruit and reprogram these tumor-associated macrophages, or TAMs, to support their own growth and confer resistance to therapies. Led by Ludwig Lausanne's Johanna Joyce and Davide Croci and their colleague at the Lausanne […]

Continue reading »

The language of loneliness and depression, revealed in social media

Loneliness is a risk factor for depression, but it can also be a symptom. Mental health professionals who treat patients experiencing both must navigate the complex relationship between the two conditions, yet also understand and treat them individually. To shed light on this, a multidisciplinary collaboration between Penn, Purdue, Stanford, and the National Institute on Drug Abuse (NIDA) combined traditional […]

Continue reading »

Blood test for long COVID: Could blood proteins predict risk?

Researchers examined the link between blood protein levels and long COVID incidence. They found that levels of certain blood proteins six weeks after contracting SARS-CoV-2 may predict long COVID risk. They noted that larger studies are needed to confirm their results. According to the World Health Organization (WHO), long COVID is characterized by symptoms that occur around three months after […]

Continue reading »

Chinas Zero-COVID Policy Seen Lingering as Cases Double From September

SHANGHAI (Reuters) -China’s daily count of new coronavirus cases has doubled since September, hardening the resolve of authorities to eliminate outbreaks as quickly as they appear and dimming hopes for an easing in their zero-COVID stance. China reported 1,624 new COVID-19 infections for Oct. 12, of which 372 were symptomatic and 1,252 asymptomatic, the National Health Commission said on Thursday. […]

Continue reading »

PSI researchers optimize a method for tumor diagnosis using radionuclides

Researchers at the Paul Scherrer Institute PSI, in collaboration with ETH Zurich, have optimized a method for tumor diagnosis using radionuclides. Potential side-effects can now be significantly reduced through a molecular trick. The researchers report their results in the current issue of the scientific journal Bioorganic & Medicinal Chemistry. With the development of a new class of so-called radiopharmaceuticals, the […]

Continue reading »
1 313 314 315 316 317 1,322